A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia
Clinical trial NCT00261573 · COMPLETED
Trial details
- NCT number
- NCT00261573
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-12-01
- Enrollment
- 593
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.